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Abstract
Introduction: Invasive and semi-invasive pulmonary aspergillosis usually occurs in immunocompromised patients. It 
has been described occasionally in patients with normal immunity and previous lung disease such as chronic 
obstructive pulmonary disease.
Swyer-James-MacLeod Syndrome is a rare condition characterized by hyperlucency of one lung, lobe or part of a lobe 
due to decreased vascularity and air trapping.
Case presentation: We report a case of semi-invasive pulmonary aspergillosis in a 38-year-old Portuguese, Caucasian 
man who is immunocompetent, with a pre-existing Swyer-James-McLeod Syndrome, a structural lung disease.
Conclusions: To the best of our knowledge, this is the first reported case in the literature on the relationship between 
these two diseases. Although rare, aspergillosis can occur in immunocompetent adults with a pre-existing lung disease 
other than chronic obstructive pulmonary disorder.
Introduction
Invasive and/or semi-invasive aspergillosis infection is
extremely rare in patients with normal immunity. It has
been described in the presence of pulmonary disease,
such as chronic obstructive pulmonary disorder (COPD),
but it can also occur in patients without pre-existent dis-
ease, usually following massive inoculums of Aspergillus.
Although rare it can be fatal [1-6].
Case presentation
A 38-year-old Portuguese, Caucasian man working in the
viticulture and forestry industry was referred to a pulmo-
nary clinic following complaints of progressive right side
pleuritic chest pain, non-productive cough, low-grade
fever, and general fatigue.
He was a former smoker (10 packs a year) and had
asymptomatic Swyer-James-MacLeod Syndrome (SJMS)
that was diagnosed at the age of 28 after a routine chest
X-ray. He also had arterial hypertension that was con-
trolled with atenolol and amiloride plus hydrochlorothi-
azide. He also reported frequent exposure to organic dust
during work.
A physical examination of our patient revealed normal
body temperature, pulse rate, respiratory rate, blood
pressure and oxygen saturation. His chest examination
revealed crackles in his lower right hemithorax. The rest
of his physical exam was unremarkable.
Blood sample analysis showed that he had no abnor-
malities except for an elevated erythrocyte sedimenta-
tion rate (ESR) (72 mm/h, normal: <20 mm/h) and C-
reactive protein (CRP) (25.95 mg/dL, normal: <1 mg/
dL). His lung function tests and arterial blood gas levels
were normal.
A plain chest X-ray disclosed a large infiltrate in the
right inferior lung field of our patient and a chest com-
puted tomography (CT) scan confirmed the presence of a
consolidation and/or a mass of 35 × 64 × 37 mm in diam-
eter located in the upper segment of the right lower lobe
and posterior segment of his right upper lobe. The mass
had direct contact with the contiguous pleura and was
associated with a small pleural effusion, and there was
also no mediastinal lymphadenopathy (Figure 1). * Correspondence: sarasalgado@netcabo.pt
1 Pulido Valente Hospital, Alameda das Linhas de Torres, Lisbon, Portugal
Full list of author information is available at the end of the articleSalgado et al. Journal of Medical Case Reports 2010, 4:153
http://www.jmedicalcasereports.com/content/4/1/153
Page 2 of 3
We initiated a therapy of levofloxacin 500 mg/day for
one week. However, our patient showed no clinical
response to this treatment.
Bronchoscopy was subsequently performed on our
patient. His bronchoalveolar lavage (BAL) fluid revealed
negative cytological, bacteriological, mycobacteriological
and mycological exams. Bronchial brushing and trans-
bronchial biopsies were also obtained and were negative
for neoplastic cells.
A transthoracic CT-guided fine needle aspiration of the
lesion was negative for neoplastic cells, but revealed fun-
gal elements.
Finally , surgical lung biopsies were performed, which
showed evidence of tissue invasion by fungal organisms
and Sabouraud glucose agar cultures isolated multiple
Aspergillus glaucus colonies. Serological tests did not
reveal elevated titres of Aspergillus antibody or antigen
(Platelia™ Aspergillus EIA, Bio-Rad).
Human immunodeficiency virus 1 and 2 tests, as well as
differential cell counts for lymphocyte subpopulations,
were performed on our patient and excluded underlying
immunosuppression.
Our final diagnosis was semi-invasive pulmonary
aspergillosis and we started him on itraconazole (400 mg
orally per day) for one year. During follow-up examina-
tion he had remained asymptomatic and repeated chest
CT revealed partial regression of the mass volume and
resolution of the pleural effusion (Figure 2). His recent
BAL fluid examination presented positive galactomannan
and negative mycological exam. Blood analysis showed
normalization of his ESR and CRP level.
He maintains treatment with itraconazol and is under
deliberation for surgical resection of the residual lesion.
Discussion
SJMS is a rare condition and was first described in 1953.
It is considered to be a post-infection form of bronchioli-
tis obliterans that develops after pulmonary infections in
childhood. Its clinical manifestations may vary from
asymptomatic forms, in which the diagnosis follows a
radiological finding, to recurrent respiratory infections
with productive cough, wheezing and occasional hemop-
tysis. Hyperlucency of the affected area (lung, lobe or part
of a lobe), diminished size of pulmonary vessels, and air
trapping are the usual findings in chest CT [7,8]. To some
extent, SJMS may have common features with COPD,
such as the existence of emphysema bullae, airflow
obstruction, air trapping, and a predisposition to respira-
tory infections.
Once Aspergillus spores are inhaled they can cause
lung infections ranging from saprophytic to invasive
forms. Its clinical presentation depends on the immune
status of the host and underlying lung diseases. In the
case we describe here, our patient was immunocompe-
tent but presented a pre-existing structural lung disease,
SJMS, and a history of probable professional inhalation of
fungal spores. The clinical picture was an indolent form
with focal disease (semi-invasive).
The diagnosis of Aspergillus infection is not always
easy as it requires detection of Aspergillus in cultures
and/or demonstration of tissue invasion by the fungus in
the histological exam. In most cases, the diagnosis is
made by tissue isolation through invasive methods, as in
this case. Serological tests are adjuncts to support or
exclude the diagnosis in the appropriate clinical context
but they do not make a definitive diagnosis. In some cases
the serum antigen level may be below the threshold of
detection and antibody titration has a limited value.
Treatment is most often prolonged or combined [9,10].
The choice of the anti-fungal was based on the normal
immune status and non-severity of the infection, which
allows for oral treatment. Itraconazole is a reasonable
drug for patients who are immunocompetent, with non-
life-threatening forms of aspergillosis. It is also less
expensive than voriconazole (the first-line agent), more
comfortable and easily accessible for patients as it is avail-
able in non-hospital pharmacies. Also, our patient had no
concomitant medication that would predict drug interac-
tion problems. Finally, there are no reports of itracon-
azole resistant A. glaucus as this type of resistance is only
described for A. fumigatus.
Figure 1 Chest computed tomography scan. (A) Areas of air-trap-
ping with hyperlucency mainly in the right upper lobe (compatible 
with Swyer-James-MacLeod Syndrome). (B) A mass with pleural con-
tact and a small pleural effusion in the right lung (semi-invasive asper-
gillosis). Figure 2 Imaging after treatment. Computed tomography scan 
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Our patient showed clinical and radiological improve-
ment with itraconazole treatment. Our patient's age,
good functional status and the lesion's reduction with
medical treatment suggests that he might be a good can-
didate for surgical resection, although another option
could be to prolong his itraconazole medication until the
complete radiological resolution of his lesions.
Conclusions
This is an original case report of interest to pulmonary
and infectious disease specialities.
To the best of our knowledge, this is the first instance in
the literature that the fact that semi-invasive aspergillosis
can occur in immunocompetent adults with pre-existing
lung disease other than COPD is highlighted. It is known
that SJMS predisposes patients to lung infections and has
also some similarities with COPD that could point out to
potential fungal infections.
In such patients, prevention of environmental exposure
should be attempted. Patients should be advised to use
mechanical filter masks if potential spore inhalation
exists and should be clinically monitored. Infections
should be diagnosed and treated as soon as possible.
Aspergillosis should be considered when an aetiological
agent is not identifiable in a patient who fails to respond
to antimicrobial agents.
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